Contribution of avoidable causes of death to premature mortality in Poland and selected European countries

• Autorzy: Bogdan Wojtyniak , Jakub Stokwiszewski
• Języki publikacji: EN

Abstrakty

EN

Our study, availing the new, agreed by the OECD and Eurostat, lists of preventable and treatable causes of death, seeks to quantify the contribution of avoidable causes to premature mortality and its dynamics in Poland and Central European countries - Czechia, Hungary, Lithuania and Slovenia, in comparison with Sweden serving as a benchmark country in 1999-2017. We calculated age standardised death rates for the broad groups of avoidable causes and more specific ones, which comprised preventable and treatable cancer and diseases of the circulatory system (DCS), preventable injuries and alcohol-related diseases. Deaths from not avoidable causes were also analysed. The analysis of time trends in the death rates and calculation of the Average Annual Percent Change (AAPC) for the overall trend were performed with joint-point models. The contribution of changes in mortality from avoidable causes to increase life expectancy during 1999-2017 and contribution of the difference in mortality from these causes to the difference in life expectancy between five countries and Sweden were based on the decomposition of temporary life expectancy between birth and age 75 [e(0-75)]. For the calculation of life expectancy, we used the classic Chiang method and the decomposition of life expectancy by the death causes and age was conducted with the Arriaga method. The AAPC of death rates from avoidable causes in 1999-2017 was similar in all the countries but Lithuania, where the decline started later. The decline in the death rates from not avoidable causes is much slower than the rates from avoidable causes. Mortality from treatable causes was decreasing faster than from preventable causes in most populations. In 1999-2017, the average rate of mortality decline for preventable cancer was greater among men than among women, while for treatable cancer the sex-related differences were much smaller and in favour of women. As for preventable and treatable death from DCS, their decrease was faster among women than men in all the countries but Sweden. Improvements in mortality from causes that could be avoided through prevention or treatment made substantial positive contributions to the overall change in life expectancy in all the countries. The differences in temporary life expectancy e(0-75) between the analysed Central European countries and Sweden were much smaller in 2017 than in 1999, due to the reduction of the gap in mortality from avoidable causes. Our results show that among men, and to a lesser extent among women, mortality from preventable causes contributes more than mortality from causes that can be effectively treated to shorter life expectancy in the countries of Central Europe than in Sweden.(original abstract)

Słowa kluczowe

PL

Umieralność; Choroby nowotworowe; Długość życia; Leczenie

EN

Mortality; Cancer; Life expectancy; Medical treatment

• Czasopismo: Studia Demograficzne
• Rocznik: 2020
• Numer: nr 2(178)
• Strony: 11-34

Twórcy

autor

Bogdan Wojtyniak

• National Institute of Public Health - National Institute of Hygiene

autor

Jakub Stokwiszewski

• National Institute of Public Health - National Institute of Hygiene

Bibliografia

• Arriaga, E. E. (1984). Measuring and Explaining the Change in Life Expectancies. "Demography", 21 (1), 83-96.
• Baker, P., Dworkin, S. L., Tong, S., Banks, I., Shande, T., Yameyf, G. (2014). The men's health gap: men must be included in the global health equity agenda. Bull World Health Organ 92, 618-620.
• Chiang, C. L. (1984). The Life Table and its Applications. Malabar, Florida: Robert E. Krieger Publishing Company, Inc.
• Clegg, L. X., Hankey, B. F., Tiwari, R., Feuer, E. J., Edwards, B. K. (2009). Estimating average annual percent change in trend analysis. "Statist. Med.", 28, 3670-3682.
• European Commission (2011). The State of Men's Health in Europe: Extended Report 2011, Luxembourg. Retrieved from: https://ec.europa.eu/health/sites/health/files/state/docs/men_health_extended_en.pdf (accessed: November 14, 2015).
• Eurostat (2013). Revision of the European Standard Population - Report of Eurostat's task force. Methodologies and Working papers, 2013 edition. Eurostat, European Commission. Luxembourg: Publications Office of the European Union.
• Eurostat (2014). Amenable and preventable deaths statistics. Retrieved from: http://ec.europa.eu/eurostat/statisticsexplained/index.php/Amenable_and_preventable_deaths_statistics (accessed: January 15, 2017).
• Gay, J., Paris, V., Devaux, M., de Looper, M. (2011). Mortality Amenable to Health Care in 31 OECD Countries: Estimates and Methodological Issues. OECD Health Working Papers, 55, OECD Publishing.
• Gierlotka, M., Zdrojewski, T., Wojtyniak, B., Poloński, L., Stokwiszewski, J., Gąsior, M., Kozierkiewicz, A., Kalarus, Z., Wierucki, Ł., Chlebus, K., Zembala, M., Wysocki, M., Opolski, G. (2015). Incidence, treatment, in-hospital and one-year outcomes of acute myocardial infraction in Poland in 2009-2012 - nationwide database AMI-PL. "Kardiologia Polska", 73 (3), 93-109.
• Karanikolos, M., Mackenbach, J. P., Nolte, E., Stuckler, D., & McKee, M. (2018). Amenable mortality in the EU - has the crisis changed its course? "The European Journal of Public Health", 28 (5), 864-869.
• Korda, R., Butler, J. R. G. (2006). Effect of healthcare on mortality: Trends in avoidable mortality in Australia and comparisons with Western Europe. "Public Health", 120 (2), 95-105.
• Nolte, E., Scholz, R., Shkolnikov, V., McKee, M. (2002). The Contribution of Medical Care to Changing Life Expectancy in Germany and Poland. "Social Science and Medicine", 55, 1905-1921.
• Nolte, E., McKee, M. (2004). Does Health Care Save Lives? Avoidable Mortality Revisited. London: Nuffield Trust.
• Nolte, E., McKee, M. (2008). Measuring the Health of Nations: Updating an Earlier Analysis, "Health Affairs", 27 (1), 58-71.
• Nolte, E., McKee, M. (2011). Variations in amenable mortality-Trends in 16 high-income nations. "Health Policy" 103 (1), 47-52.
• OECD, Eurostat (2019, November). Avoidable mortality: OECD/Eurostat lists of preventable and treatable causes of death (November 2019 version). Retrieved from: http://www.oecd.org/health/health-systems/Avoidable-mortality-2019 Joint-OECD-Eurostat-List-preventable-treatable-causes-of-death.pdf (accessed: April 24, 2020).
• ONS (2011). Definition of avoidable mortality. Retrieved from: http://www.ons.gov.uk/ons/about-ons/getinvolved/consultations/archived-consultations/2011/definitions-of-avoidable-mortality/definitionof-avoidable-mortality.pdf (accessed: May 9, 2016).
• Rutstein, D., Berenberg, W., Chalmers, T. C., Child, C. G., Fishman, A. P., Perrin, E. B., (1976). Measuring the Quality of Medical Care. "A Clinical Method, New England Journal of Medicine", 294 (11), 582-588.
• Simonato, L., Ballard, T., Bellini, P., Winkelmann, R. (1998). Avoidable mortality in Europe 1955-1994: a plea for prevention." J Epidemiol Community Health", 52, 624- 630.
• Velkova, A., Wolleswinkel-van den Bosch, J. H., Mackenbach, J. P. (1997). The east-west life expectancy gap: Differences in mortality from conditions amenable to medical intervention." Int J Epidemiol" 26, 75-84.
• WHO Regional Office for Europe (2018). The health and well-being of men in the WHO European Region: better health through a gender approach. Retrieved from: https://www.euro.who.int/en/health-topics/health-determinants/gender/publications/2018/the-health-and-well-being-of-men-in-the-who-european-region-better--health-through-a-gender-approach-2018 (accessed: April 28, 2019).
• WHO (2019). WHO Health statistics and information systems. Retrieved from: https://www.who.int/healthinfo/statistics/mortality_rawdata/en/ (accessed: May 7, 2020).
• Wróblewska, W. (2012). Zgony możliwe do uniknięcia - opis koncepcji oraz wyniki analizy dla Polski. "Studia Demograficzne", 1 (161), 129-151.
• Wróblewska, W. (2017). Territorial variation in mortality from causes amenable to medical care in Poland. "Ann Agric Environ Med.", 24 (3), 489-495.

Identyfikatory

DOI

https://doi.org/10.33119/SD.2020.2.4